NovoCure Limited Banner Image

NovoCure Limited

  • Ticker NVCR
    Exchange NASDAQ More
  • Industry Medical Laboratories & Research More
  • Sector Healthcare More
NovoCure Limited Logo Image
  • 201-500 Employees
  • Based in Portsmouth, New Hampshire
Novocure is an oncology company developing a profoundly different cancer treatment centered on a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma.
NovoCure Limited

Most Recent Annual Report

NovoCure Limited
MOST RECENT 2021 Annual Report and Form 10K

NovoCure Limited does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports